Conexeu Sciences Announces $5 Million Private Placement
The $5 million private placement is led by existing shareholders, management and directors.
Story updates
08:37:45 PM UTC
SquawkNews
Financing involving participation from the CEO and Chief Commercial Officer, supports manufacturing scale-up, regulatory testing and preclinical work toward the Company’s planned FDA 510(k) submission in the first quarter of 2027RENO, Nev., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. NA…
08:38:10 PM UTC
SquawkNews
Conexeu Sciences closed a ~$5M private placement of 1,666,667 units at $3.00, each with a share and a 24—month $3.00 warrant; $250K from insiders is escrowed pending stockholder approval.Material DetailsContext by AI AnalystThis funding supports a preclinical company advancing toward an anticipated…